Early research (Phase 1)Ended earlyNCT05660265
What this trial is testing
Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
Who this might be right for
Hematologic DiseasesAnaemia, Sickle Cell
GlaxoSmithKline 11